MedTrace Logo

Evolving Treatment Modalities for Management of Patients Suffering From Disc Displacement With Reduction

NCT05194488 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2023-12-04

No results posted yet for this study

Summary

Aim of the current study is to compare the efficacy of Low Level Laser, Botulinum toxin type A, and repositioning appliance in management of reduced temporomandibular joint disc.

Conditions

  • Temporomandibular Joint Disc Displacement, With Reduction

Interventions

DEVICE

Low level laser therapy

Patients will receive low-level laser therapy on the temporomandibular joint disc

DRUG

Botulinum toxin type A

Patients will receive Botulinum toxin type A injection into the lateral pterygoid muscle under Electromyography (EMG) guidance.

DEVICE

Anterior repositioning appliance

Patients will receive hard maxillary anterior repositioning appliance.

Sponsors & Collaborators

  • Nourhan M.Aly

    lead OTHER

Principal Investigators

  • Mariam M Bahgat, M.Sc · Faculty of Dentistry, Alexandria University, Egypt

  • Nermeen A Rady, PhD · Faculty of Dentistry, Alexandria University, Egypt

  • Ahmed M Abdelhamid, PhD · Faculty of Dentistry, Alexandria University, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2022-05-20
Completion
2022-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05194488 on ClinicalTrials.gov